menu
    • menu

    Company profile for Fulcrum Therapeutics

    NEW Drugs in Dev: 3
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We launched Fulcrum Therapeutics with a bold vision: To change the course of genetically defined diseases by treating them at their root cause. Our approach to drug discovery generates significant insights into disease biology and allows us to think creatively about the best way to modulate and balance gene expression. The result: A patient-focused product engine designed to systematically identify and validate cellular drug ...
    We launched Fulcrum Therapeutics with a bold vision: To change the course of genetically defined diseases by treating them at their root cause. Our approach to drug discovery generates significant insights into disease biology and allows us to think creatively about the best way to modulate and balance gene expression. The result: A patient-focused product engine designed to systematically identify and validate cellular drug targets that can modulate gene expression to treat the known root cause of genetically defined diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Fulcrum TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    26 Landsdowne Street Cambridge, MA 02139
    Telephone
    Telephone
    617-651-8851
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.fulcrumtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/fulcrum-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/fulcrumtx/

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioProcess International US West

    Not Confirmed

    envelop Contact Supplier

    BioProcess International US West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fulcrum Therapeutics Joins Leerink Partners Healthcare Conference
    Fulcrum Therapeutics Joins Leerink Partners Healthcare Conference

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248361/0/en/Fulcrum-Therapeutics-to-Participate-in-the-Leerink-Partners-Global-Healthcare-Conference.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Fulcrum Therapeutics Announces Positive 12-Week Pociredir Results
    Fulcrum Therapeutics Announces Positive 12-Week Pociredir Results

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3243339/0/en/Fulcrum-Therapeutics-Announces-Positive-12-Week-Results-from-the-20-mg-Dose-Cohort-of-the-Phase-1b-PIONEER-Trial-of-Pociredir-in-Sickle-Cell-Disease.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    Fulcrum Pharma Reveals Key Business Updates And 2025 Financials
    Fulcrum Pharma Reveals Key Business Updates And 2025 Financials

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3243387/0/en/Fulcrum-Therapeutics-Announces-Recent-Business-Highlights-and-Financial-Results-for-Fourth-Quarter-and-Full-Year-2025.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    Fulcrum to Present Ph1b Pociredir Data in SCD Disease
    Fulcrum to Present Ph1b Pociredir Data in SCD Disease

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3239222/0/en/Fulcrum-Therapeutics-to-Present-12-Week-Data-from-the-20-mg-Dose-Cohort-of-the-Phase-1b-PIONEER-Trial-of-Pociredir-in-Sickle-Cell-Disease.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Fulcrum Therapeutics Discloses Inducement Grants Per Nasdaq Lr
    Fulcrum Therapeutics Discloses Inducement Grants Per Nasdaq Lr

    06 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/06/3234086/0/en/Fulcrum-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    06 Feb 2026
    Share Share
    Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Rules
    Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Rules

    09 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/09/3216358/0/en/Fulcrum-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    09 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search